Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.18
-0.0300-2.48%
Post-market: 1.190.0099+0.84%19:59 EDT
Volume:5.02M
Turnover:5.94M
Market Cap:121.54M
PE:-1.14
High:1.24
Open:1.23
Low:1.15
Close:1.21
52wk High:2.98
52wk Low:0.5632
Shares:103.00M
Float Shares:95.79M
Volume Ratio:0.73
T/O Rate:5.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0338
EPS(LYR):-1.8117
ROE:-409.87%
ROA:-84.23%
PB:27.81
PE(LYR):-0.65

Loading ...

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 23

Analysts Are Bullish on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Vera Therapeutics (VERA)

TIPRANKS
·
May 22

Inovio Says China Partner Reported VGX-3100 Phase 3 Trial Met Primary Efficacy Endpoint in Cervical Dysplasia Patients

MT Newswires Live
·
May 22

Inovio Pharmaceuticals Inc. Stock Advances 8.1%, Outperforms Peers

Dow Jones
·
May 22

Inovio partner ApolloBio says VGX-3100 Phase 3 cervical dysplasia trial hits endpoint

Reuters
·
May 22

Positive Topline Results From a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by Apollobio, Inovio's Partner in China

THOMSON REUTERS
·
May 22

Inovio Pharmaceuticals Inc - VGX-3100 Phase 3 Trial Meets Primary Endpoint With Favorable Safety Profile

THOMSON REUTERS
·
May 22

Inovio Pharmaceuticals Inc - Apollobio to Pursue Regulatory Submission for VGX-3100 in China

THOMSON REUTERS
·
May 22

Inovio Pharmaceuticals held annual shareholder meeting, investors elected eight directors

Reuters
·
May 21

Inovio’s INO‑3107 Nears PDUFA Amid Cash Squeeze

TIPRANKS
·
May 20

Inovio Pharmaceuticals Inc. Stock Slides 6.2%, Underperforms Peers

Dow Jones
·
May 19

Inovio Pharmaceuticals Earnings Call: Progress Amid Cash Strain

TIPRANKS
·
May 15

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 15

Inovio Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

BRIEF-Inovio Reports First Quarter 2026 Financial Results And Recent Business Highlights

Reuters
·
May 14

Inovio Pharmaceuticals posts flat Q1 net loss

Reuters
·
May 14

Inovio Pharmaceuticals Q1 EPS USD -0.28

THOMSON REUTERS
·
May 14

Inovio Pharmaceuticals Q1 EPS $(0.28) Beats $(0.36) Estimate, Sales $0.000 Miss $250.000K Estimate

Benzinga Earnings
·
May 14

Inovio Pharmaceuticals Inc - FDA Actively Reviewing Ino-3107 Bla Under Accelerated Approval With Pdufa Date Oct 30, 2026

THOMSON REUTERS
·
May 14

Inovio Pharmaceuticals Inc - Anticipates Cash Will Fund Operations Into Q1 2027, Beyond Pdufa Date

THOMSON REUTERS
·
May 14